Why the study?
Does AL 721 reduce HTLV-III infectivity in human T-cells in vitro?
Population
Human peripheral-blood lymphocytes or an immortalized helper T-cell line (H9) infected with HTLV-III
Comparison
AL 721 (a lipid compound) vs Control
Design
Preclinical
Follow-up
4 days (in vitro)
Authors
Loading...
AL 721 shows in vitro HTLV-III inhibition; leaves open any clinical role in AIDS pending in vivo trials.
Does AL 721 reduce HTLV-III infectivity in human T-cells in vitro?
AL 721 demonstrates in vitro inhibition of HTLV-III infectivity, suggesting potential as a novel therapeutic candidate for AIDS.
Ps et al. (1985) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: